Ricardo Blanco

Santander, CB, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 403 publications

Secukinumab for Giant Cell Arteritis.

Secukinumab for Giant Cell Arteritis.

Journal: NEJM evidence

Published: June 03, 2026

Leukocyte Telomere Length and Long-Term Clinical Outcomes in Women with Systemic Lupus Erythematosus: A Prospective Cohort Study.

Leukocyte Telomere Length and Long-Term Clinical Outcomes in Women with Systemic Lupus Erythematosus: A Prospective Cohort Study.

Journal: Journal of clinical medicine

Published: May 14, 2026

The Effectiveness of Janus Kinase Inhibitors for the Management of Relapsing Takayasu Arteritis: A Spanish Real-World Study and Comprehensive Review of the Literature.

The Effectiveness of Janus Kinase Inhibitors for the Management of Relapsing Takayasu Arteritis: A Spanish Real-World Study and Comprehensive Review of the Literature.

Journal: Life (Basel, Switzerland)

Published: May 14, 2026

Deucravacitinib in Active Psoriatic Arthritis: Efficacy and Safety up to 52 Weeks From the Randomized, Double-Blind, Phase 3 POETYK PsA-2 Trial.

Deucravacitinib in Active Psoriatic Arthritis: Efficacy and Safety up to 52 Weeks From the Randomized, Double-Blind, Phase 3 POETYK PsA-2 Trial.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: May 12, 2026

Long-term vascular outcomes and biological predictors of thrombosis in systemic lupus erythematosus: a 10-year prospective cohort study.

Long-term vascular outcomes and biological predictors of thrombosis in systemic lupus erythematosus: a 10-year prospective cohort study.

Journal: European journal of internal medicine

Published: April 07, 2026

Window of opportunity with abatacept in Rheumatoid arthritis-associated interstitial lung disease: A multicentre study of 526 patients.

Window of opportunity with abatacept in Rheumatoid arthritis-associated interstitial lung disease: A multicentre study of 526 patients.

Journal: European journal of internal medicine

Published: April 01, 2026

Refractory lupus nephritis: national multicenter study.

Refractory lupus nephritis: national multicenter study.

Journal: Internal and emergency medicine

Published: March 24, 2026

Advances in the management of giant cell arteritis-aortitis: biologic therapies and beyond - a narrative review.

Advances in the management of giant cell arteritis-aortitis: biologic therapies and beyond - a narrative review.

Journal: Expert opinion on biological therapy

Published: March 23, 2026

Cocaine-induced ANCA-associated vasculitis: Cohort analysis from a referral center and literature review.

Cocaine-induced ANCA-associated vasculitis: Cohort analysis from a referral center and literature review.

Journal: European journal of internal medicine

Published: February 24, 2026

Expert review and recommendations on the diagnosis and therapeutic management of eosinophilic granulomatosis with polyangiitis.

Expert review and recommendations on the diagnosis and therapeutic management of eosinophilic granulomatosis with polyangiitis.

Journal: Frontiers in immunology

Published: January 12, 2026

Anifrolumab in systemic lupus erythematosus: real-world evidence from a Spanish multicentre cohort of 206 patients and literature review.

Anifrolumab in systemic lupus erythematosus: real-world evidence from a Spanish multicentre cohort of 206 patients and literature review.

Journal: RMD open

Published: December 22, 2025

Long-term safety and efficacy of upadacitinib compared with adalimumab in patients with rheumatoid arthritis: 7-year data from the SELECT-COMPARE study.

Long-term safety and efficacy of upadacitinib compared with adalimumab in patients with rheumatoid arthritis: 7-year data from the SELECT-COMPARE study.

Journal: RMD open

Published: December 22, 2025

Showing 1-12 of 403

Last Updated: 09/26/2026